Product image of Oroset (Ondansetron) supplied by GNH India

Oroset

Active Ingredient:
Ondansetron
Origin:
EU

Oroset (Ondansetron)

Ondansetron, the active ingredient in Oroset, is a 5‑HT3 receptor antagonist presented as an oral tablet for oral use. It prevents nausea and vomiting associated with chemotherapy, postoperative recovery, and radiation therapy.

GNH India supplies Oroset as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Hcm Pharma Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oroset, a selective 5‑HT3 receptor antagonist, is used to control nausea and vomiting in several clinical settings.

  • Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of nausea and vomiting caused by anticancer drugs.
  • Postoperative nausea and vomiting: lowers the incidence of nausea and vomiting after surgical procedures.
  • Radiation‑induced nausea and vomiting: helps control symptoms in patients receiving radiotherapy.

How It Works

  • Ondansetron works by selectively blocking serotonin (5‑HT3) receptors located in the central nervous system and gastrointestinal tract. By inhibiting these receptors, it prevents serotonin‑mediated signaling that triggers the vomiting reflex, thereby reducing nausea and vomiting associated with chemotherapy, surgery, and radiation therapy.

Side Effects

Common Side Effects

  • Headache: mild to moderate pain in the head region.
  • Constipation: reduced bowel movements leading to hard stools.
  • Diarrhoea: loose, watery stools.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: feeling unusually tired or weak.
  • Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects

  • QT interval prolongation: potential heart rhythm disturbances.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Serotonin syndrome: agitation, fever, rapid heart rate when combined with other serotonergic drugs.
  • Cardiac arrhythmias: irregular heartbeats that may be life‑threatening.
  • Stevens‑Johnson syndrome: severe skin blistering and detachment.
  • Hepatic dysfunction: abnormal liver enzyme elevations.

Precautions & Warnings

Before prescribing, consider the following precautions:

  • Cardiac risk assessment: evaluate patient history for arrhythmias or prolonged QT interval.
  • Electrolyte monitoring: correct hypokalaemia or hypomagnesaemia which can exacerbate QT prolongation.
  • Hepatic impairment: adjust use in patients with severe liver dysfunction.
  • Hypersensitivity: avoid in individuals with known allergy to ondansetron or similar compounds.
  • Concomitant QT‑prolonging drugs: use with caution when other agents that affect cardiac repolarisation are present.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Ondansetron may interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid)

  • Apomorphine: co‑administration can cause severe hypotension and loss of consciousness.
  • Other QT‑prolonging agents (e.g., quinidine, erythromycin, haloperidol): increase risk of cardiac arrhythmias.
  • Carbamazepine: induces metabolism, potentially reducing ondansetron efficacy.

Moderate Interactions (Monitor Closely)

  • Aprepitant: may increase ondansetron plasma concentrations.
  • Dexamethasone: combined use may enhance anti‑emetic effect.
  • Serotonergic drugs (e.g., SSRIs, tramadol): monitor for signs of serotonin syndrome.

Frequently Asked Questions

Oroset contains ondansetron, which is prescribed to prevent and treat nausea and vomiting that can occur after chemotherapy, surgery, or radiation therapy. It is commonly used in oncology, surgical, and radiotherapy settings to improve patient comfort and reduce the need for additional anti‑emetic medications.

Ondansetron blocks serotonin (5‑HT3) receptors in the brain and gastrointestinal tract. By inhibiting these receptors, it stops the signal cascade that triggers the vomiting reflex, thereby reducing nausea and vomiting associated with chemotherapy, postoperative recovery, and radiation treatment.

The dosage of Oroset is determined by the prescribing clinician based on the specific clinical situation, such as the type of chemotherapy or surgery. The prescriber will select the appropriate strength, frequency, and duration according to established treatment guidelines.

Safety of ondansetron during pregnancy or lactation has not been definitively established. Healthcare providers should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. Pregnant or nursing patients should discuss use with their physician.

To order Oroset, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Oroset (ondansetron) is a selective 5‑HT3 antagonist, offering targeted control of serotonin‑mediated nausea. Compared with broader‑acting agents such as dopamine antagonists, ondansetron typically provides more effective prevention of chemotherapy‑induced vomiting with a lower incidence of extrapyramidal side effects.

Oroset should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Oroset is taken orally, usually with a glass of water. The tablet is swallowed whole and should be taken as directed by the prescriber, often before the start of chemotherapy, surgery, or radiation therapy to maximize its anti‑emetic effect.

Serious risks include QT interval prolongation, which can lead to cardiac arrhythmias, and rare severe allergic reactions such as anaphylaxis. Patients should be monitored for signs of cardiac irregularities, especially if they are taking other QT‑prolonging medications.

Oroset should not be used by individuals with known hypersensitivity to ondansetron or any component of the formulation. Caution is also advised for patients with a history of prolonged QT interval, significant cardiac disease, or those taking medications that strongly affect cardiac repolarisation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT